Zhao Yi-Miao, Liu Lin, Sun Jie, Yan Wei, Yuan Kai, Zheng Yong-Bo, Lu Zheng-An, Liu Lin, Ni Shu-Yu, Su Si-Zhen, Zhu Xi-Mei, Zeng Na, Gong Yi-Miao, Wu Ping, Ran Mao-Sheng, Leng Yue, Shi Jie, Shi Le, Lu Lin, Bao Yan-Ping
National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing 100191, China.
School of Public Health, Peking University, Beijing 100191, China.
Vaccines (Basel). 2021 Oct 13;9(10):1172. doi: 10.3390/vaccines9101172.
The present study assessed the willingness of the general population to receive COVID-19 vaccines and identified factors that influence vaccine hesitancy and resistance. A national online survey was conducted from 29 January 2021 to 26 April 2021 in China. Multinomial logistic regression analyses were conducted to identify factors that influence vaccine hesitancy and resistance. Of the 34,041 participants surveyed, 18,810 (55.3%) were willing to get vaccinated, 13,736 (40.3%) were hesitant, and 1495 (4.4%) were resistant. Rates of vaccine acceptance increased over time, with geographical discrepancies in vaccine hesitancy and resistance between provinces in China. Vaccine safety was the greatest concern expressed by most participants (24,461 [71.9%]), and the major reason for participants' refusing vaccination (974 [65.2%]). Government agencies (23,131 [68.0%]) and social media (20,967 [61.6%]) were the main sources of COVID-19 vaccine information. Compared with vaccination acceptance, female, young and middle-aged, high income, and perceived low-risk of infection were associated with vaccine hesitancy. Histories of allergic reactions to other vaccines and depression symptoms were related to vaccine resistance. Common factors that influenced vaccine hesitancy and resistance were residing in cities and perceiving less protection with vaccines than with other protective measures. The results indicate that the rate of vaccine resistance is relatively low, but vaccine hesitancy is common. Individuals who are female, young and middle-aged, with a high income, and residing in cities are more likely to be hesitant for vaccination and should be the target populations for vaccination campaigns. Specific vaccine messaging from the government and social media could alleviate public concerns about vaccine safety and efficacy.
本研究评估了普通人群接种新冠疫苗的意愿,并确定了影响疫苗犹豫和抵触的因素。2021年1月29日至2021年4月26日在中国进行了一项全国性在线调查。进行多项逻辑回归分析以确定影响疫苗犹豫和抵触的因素。在34041名接受调查的参与者中,18810名(55.3%)愿意接种疫苗,13736名(40.3%)犹豫不决,1495名(4.4%)抵触。疫苗接受率随时间增加,中国各省之间在疫苗犹豫和抵触方面存在地域差异。疫苗安全性是大多数参与者(24461名[71.9%])表达的最大担忧,也是参与者拒绝接种疫苗的主要原因(974名[65.2%])。政府机构(23131名[68.0%])和社交媒体(20967名[61.6%])是新冠疫苗信息的主要来源。与接种接受情况相比,女性、中青年、高收入以及感知感染风险低与疫苗犹豫有关。对其他疫苗的过敏反应史和抑郁症状与疫苗抵触有关。影响疫苗犹豫和抵触的常见因素是居住在城市以及认为疫苗提供的保护不如其他防护措施。结果表明,疫苗抵触率相对较低,但疫苗犹豫很常见。女性、中青年、高收入且居住在城市的个体更有可能对接种疫苗犹豫不决,应成为疫苗接种运动的目标人群。政府和社交媒体提供的特定疫苗信息可以减轻公众对疫苗安全性和有效性的担忧。